AE Wealth Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
AIM
NAMA
DM
AE Wealth Management's EDIT Position: Q1 2020 in Review
AE Wealth Management sold out of Editas Medicine (EDIT) in Q1 2020, closing a stake of 27,149 shares — an estimated $804K sold.
AE Wealth Management first reported a position in EDIT in Q2 2019 and held it in 3 quarters. The position peaked at $804K in Q4 2019. 199 funds tracked by Wall St. Rank hold EDIT as of Q1 2020.
- AE Wealth Management reported no remaining Editas Medicine position as of Q1 2020 after selling out during the quarter.
- AE Wealth Management sold 27,149 Editas Medicine shares in Q1 2020, an estimated $804K.
- AE Wealth Management first reported a position in Editas Medicine in Q2 2019 and held it in 3 quarters.
- AE Wealth Management's Editas Medicine position peaked at $804K in Q4 2019.
- 199 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2020.
Based on AE Wealth Management's 13F filing for Q1 2020, filed 7 May 2020.